MBX Biosciences (MBX) Other Non-Current Assets (2023 - 2026)

MBX Biosciences has reported Other Non-Current Assets for 4 years, with the latest figure at $200000.0 in Q1 2026.

• Quarterly Other Non-Current Assets rose 300.0% year-over-year to $200000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200000.0 (up 300.0% YoY) and the FY2024 annual result came in at $50000.0, changed 0.0% from the prior year.
• Other Non-Current Assets rose to $200000.0 in Q1 2026 per MBX's latest filing, from $50000.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $200000.0 in Q1 2026 and troughed at $50000.0 in Q4 2023.
• A 4-year average of $71428.6 and a median of $50000.0 in 2023 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2024 and 2026: Other Non-Current Assets changed 0.0% in 2024, then soared 300.0% in 2026.
• Over 4 years, Other Non-Current Assets stood at $50000.0 in 2023, then changed by 0.0% to $50000.0 in 2024, then changed by 0.0% to $50000.0 in 2025, then jumped by 300.0% to $200000.0 in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $200000.0, $50000.0, and $50000.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.